Panama approves purchase of COVID-19 vaccine from British AstraZeneca

Laurentino Cortizo Cohen, President of Panama. Photo: Courtesy of the Presidency of Panama.
Editorial Dept. Voz de la Diaspora

The Panamanian government authorized 4.3 million dollars for the purchase of a million 92 1,000 doses of the vaccine against COVID-19 developed by the British pharmaceutical company AstraZeneca and the University of Oxford, authorities said.

The Presidency of Panama said that the Cabinet Council authorized the Ministry of Health to manage the purchase of vaccines, as well as the payment of an advance of the 20% of the total cost before 30 of November.

The vaccine that is in phase III of research with applied trials in thousands of volunteers, is ready to present its protocols to international organizations, that must be certified as a safe and effective vaccine, According to the official statement.

The Panamanian government announced that it has designed a strategy whose goal is to guarantee access to the most efficient and safe vaccines that are approved in order to immunize the entire population of 4.2 millions of inhabitants, with a double dose for each person.

As part of the plan, last September he confirmed that he joined the COVAX mechanism led by the World Health Organization through which countries seek to ensure access to vaccines.

For his part, the Panamanian president, Laurentino Cortizo confirmed last week the approval of 48 million dollars for the purchase of vaccines against COVID-19.

Cortizo explained that the purchase is planned 4 million doses to the pharmaceutical company Pfizer, whose vaccine turned out to be a 95% effective at the end of the tests, as announced by the company.

Panama, is one of the Central American countries with the highest incidence of COVID-19, until the 18 November reported a cumulative total of 149,833 contagions, from those 2,907 lost their lives from the disease since the coronavirus outbreak began.